| Financial Year |
March 31 2023 |
| Monetary Funds |
767,442,215.79 |
| Held-for-trading Financial Assets |
15,200,000.00 |
| Notes Receivable |
215,799,509.33 |
| Accounts Receivable |
1,358,222,981.97 |
| Advances to Suppliers |
177,272,072.50 |
| Other Receivables |
24,642,169.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
863,276,357.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
99,409,208.16 |
| Total Current Assets |
3,538,908,812.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,868,484.58 |
| Investment Properties |
11,068,032.44 |
| Fixed Assetes |
2,783,400,136.50 |
| Under-construction Projects |
432,647,358.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
363,573,772.53 |
| R&D expenses |
-- |
| Goodwill |
146,569,875.06 |
| Long-Term Deferred and Prepaid Expenses |
31,457,425.24 |
| Deferred Income Tax Assets |
76,890,580.36 |
| Other Non-Current Assets |
90,183,642.83 |
| Sub-Total of Non-Current Assets |
4,042,920,621.00 |
| Total Assets |
7,581,829,433.44 |
| Short-Term Loans |
1,238,383,929.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,160,188,352.88 |
| Accounts Payable |
944,696,638.96 |
| Accounts Received In Advance |
420,352.51 |
| Employee Compensation Payable |
39,446,039.83 |
| Taxes Payable |
46,138,427.75 |
| Interest Payable |
-- |
| Dividend Payable |
498,071.13 |
| Other payables |
76,497,957.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
181,291,957.07 |
| Other Current Liabilities |
7,162,612.97 |
| Sub-Total of Current Liabilities |
3,750,939,314.57 |
| Long-term Loans |
761,661,007.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
25,798,663.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,648,089.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
942,942,293.63 |
| Total Liabilities |
4,693,881,608.20 |
| Paid-In Capital(Or Share Stock) |
976,918,468.00 |
| Capital Surplus |
859,019,654.63 |
| Surplus Reserve |
60,904,353.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
941,925,950.84 |
| Minority Stockholder's Interest |
52,663,278.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,835,284,547.20 |
| Owner's Equity（Stockholder's Equity） |
2,887,947,825.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,581,829,433.44 |
